http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201070061-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J21-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J21-00
filingDate 2008-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201070061-A1
titleOfInvention INDUSTRIAL METHOD FOR SYNTHESIS OF 17-ACETOXY-11β- [4- (DEMITILAMINO) PHENYL] -21-METHOXI-19-NORPREGN-4,9-DIEN-3,20-DIONA AND KEY INTERMEDIATE CONNECTIONS OF THIS SPOT
abstract The present invention relates to a method for the synthesis of the known 17-acetoxy-11β- [4- (dimethylamino) phenyl] -21-methoxy-19-norpregn-4,9-diene-3,20-dione (hereinafter referred to as CDB-4124) of the formula (I) from 3,3- [1,2-ethanediyl-bis (oxy)] -estr-5 (10), 9 (11) -diene-17-one of the formula (II). Compound CDB-4124 belongs to the group of antihormones. The method of the present invention is as follows: i) double-bonded epoxide formation at position 5 (10) by reaction of 3,3- [1,2-ethanediyl bis (hydroxy)] -estr-5 (10), 9 (11) diene-17-one of formula (II) with hydrogen peroxide; ii) attaching the in situ obtained cyanide to position 17 of the obtained 5,10α-epoxy-3,3- [1,2-ethanediyl bis (hydroxy)] - 5α-oestr-9 (11) -en-17-one of the formula ( III); iii) silylation of the hydroxyl group at position 17 of the resulting 5,10α-epoxy-3,3- [1,2-ethanediyl bis (hydroxy)] - 17α-hydroxy-5α-oestra-9 (11) -en-17p-carbonitrile formula (IV) trimethylchlorosilane; iv) the interaction of the obtained 5,10α-epoxy-3,3- [1,2-ethanediyl-bis (oxy)] - 17- [trimethylsilyloxy] -5α-oestra-9 (11) -en-17β-carbonitrile of the formula (V ) with Grignard reagent 4- (dimethylamino) phenylmagnesium bromide in the presence of CuCl (Toych reaction); v) silylation of the hydroxyl group at position 5 of the obtained 11β- [4- (dimethylamino) phenyl] -3,3- [1,2-ethanediyl-bis (oxy)] - 5-hydroxy-17α- [trimethylsilyl- (oxy)] -5α-oestr-9en-17β-carbonitrile of the formula (VI) with trimethylchlorosilane; vi) the interaction of the obtained 11β- [4- (dimethylamino) phenyl] -3,3- [1,2-ethanediyl bis (hydroxy)] - 5.17α-bis- [trimethylsilyl- (hydroxy)] - 5α-oestra- 9-ene 17β-carbonitrile of the formula (VII) with diisobutylaluminum hydride and the subsequent addition of acid to the reaction mixture; vii) methoxymethylation of the obtained 11β- [4- (dimethylamino) phenyl] -3,3- [1,2-ethanediyl-bis (oxy)] - 5.17α-bis- [trimethylsilyl- (oxy)] - 5α- oestra-9-en-17β-carbaldehyde of the formula (VIII) with Grignard methoxymethyl reagent obtained in situ, with the simultaneous hydrolysis of trimethylsilyl protecting groups; viii) oxidation of the hydroxyl group at position 20 of the obtained 17,20ξ-dihydroxy-11β- [4- (dimethylamino) phenyl] -21-methoxy-19-norpregn-4,9-dien-3-one of the formula (IX) with dicyclohexylcarbodiimide in the presence of dimethyl sulfoxide and a strong organic acid (Shvern oxidation), and in this case subsequent chromatographic purification; ix) acetylation of the hydroxyl group at position 17 of the obtained 11β- [4- (dimethylamino) phenyl] -17-hydroxy-21-methoxy-19-norpregn-4,9-diene-3,20-dione of formula (X) with acetic anhydride in the presence of perchloric acid, and in this case, the obtained 7-acetoxy-11β- [4- (dimethylamino) phenyl)] - 21-methoxy-19-nopregna-4,9-diene-3,20-dione of the formula (I) is purified by chromatography. The present invention also relates to new intermediates of formula (VII) and (VIII).
priorityDate 2007-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457765275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393790
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456726312

Total number of triples: 43.